Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aelis Farma SA
AELISCurrent price
2.98 EUR
-0.06 EUR (-1.97%)
Last closed
2.98 EUR
Company
www.aelisfarma.com
ISIN
FR0014007ZB4
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Paris
Capitalization
42 311 589 EUR
Yield for 12 month
-77.76 %
1Y
3Y
5Y
10Y
15Y
AELIS
Aelis Farma SA, a clinical-stage biotechnology company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders. It is developing signaling-specific inhibitors of the CB1 receptors, such as AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; and AEF0217, a drug candidate, which is in phase I/II clinical trials to treat cognitive deficits observed in Down syndrome, as well as other cognitive impairments. The company was incorporated in 2013 and is headquartered in Bordeaux, France. Address: 146 rue Lafaurie de Monbadon, Bordeaux, France, 33 000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
14.2 EURP/E ratio
–Dividend Yield
–Current Year
+9 133 408 EUR
Last Year
+3 842 407 EUR
Current Quarter
+2 080 083 EUR
Last Quarter
+2 080 083 EUR
Current Year
+12 466 385 EUR
Last Year
+3 842 407 EUR
Current Quarter
+2 080 083 EUR
Last Quarter
+2 080 083 EUR
Key Figures AELIS
1 year
3 years
5 years
10 years
EBITDA
-7 620 252 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-17.67 %
PEG Ratio
–
Return On Equity TTM
-51.97 %
Wall Street Target Price
14.2 EUR
Revenue TTM
10 875 554 EUR
Book Value
0.76 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-27.7 %
Dividend Yield
–
Gross Profit TTM
10 856 388 EUR
Earnings per share
-0.53 EUR
Diluted Eps TTM
-0.53 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-65.19 %
Dividend Analytics AELIS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AELIS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation AELIS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
4.5248
Price Sales TTM
3.8905
Enterprise Value EBITDA
37.9001
Price Book MRQ
4.1914
Financials AELIS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AELIS
For 52 weeks
3.01 EUR
13.72 EUR
50 Day MA
4.59 EUR
Shares Short Prior Month
–
200 Day MA
10.8 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart